Geneva Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Geneva Advisors’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$494K	Hold	15,330	–	–	0.01%	518
2017 Q1	$433K	Sell	15,330 -13	-0.1%	-$345	0.01%	532
2016 Q4	$371K	Buy	15,343 +13	+0.1%	+$319	0.01%	541
2016 Q3	$364K	Hold	15,330	–	–	0.01%	534
2016 Q2	$282K	Hold	15,330	–	–	0.01%	559
2016 Q1	$159K	Hold	15,330	–	–	﹤0.01%	623
2015 Q4	$232K	Hold	15,330	–	–	﹤0.01%	549
2015 Q3	$243K	Hold	15,330	–	–	﹤0.01%	528
2015 Q2	$405K	Hold	15,330	–	–	0.01%	466
2015 Q1	$598K	Hold	15,330	–	–	0.01%	382
2014 Q4	$461K	Hold	15,330	–	–	0.01%	424
2014 Q3	$362K	Buy	+15,330	New	+$436K	0.01%	480

Other funds holding CSII

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geneva Advisors's CSII Position: Q2 2017 in Review

Geneva Advisors held its Cardiovascular Systems, Inc. (CSII) position steady in Q2 2017 at 15,330 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #518.

Geneva Advisors first reported a position in CSII in Q3 2014 and has held it in 12 quarters since. The position peaked at $598K in Q1 2015. 157 funds tracked by Wall St. Rank hold CSII as of Q2 2017.

Geneva Advisors held 15,330 shares of Cardiovascular Systems, Inc. worth $494K as of Q2 2017.
Geneva Advisors left its Cardiovascular Systems, Inc. share count unchanged in Q2 2017.
Cardiovascular Systems, Inc. made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #518 holding.
Geneva Advisors first reported a position in Cardiovascular Systems, Inc. in Q3 2014 and has held it in 12 quarters since.
Geneva Advisors's Cardiovascular Systems, Inc. position peaked at $598K in Q1 2015.
157 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.